Compounds, methods and pharmaceutical compositions for inhibiting PARP

Details for Australian Patent Application No. 2010206033 (hide)

Owner Eisai Inc.

Inventors Kalish, Vincent J.; Zhang, Jie; Xu, Weizheng; Li, Jia-He; Xing, Amy D.

Agent Griffith Hack

Pub. Number AU-A-2010206033

Parent 2004242947

Filing date 29 July 2010

Wipo publication date 19 August 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07F 9/6561 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

19 August 2010 Application Open to Public Inspection

  Published as AU-A-2010206033

19 August 2010 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206034-Solar collector and solar hot water system

2010206032-Methods of treating patients having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension